Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Thirty years of HIV research but many questions still unanswered

This article was originally published in Scrip

Executive Summary

It’s hard to believe that it’s thirty years since the AIDS crisis broke. At the time, the cause of the disease was unknown, but the enormous resources devoted to tackling the crisis, both by governments and by industry, meant that not only was the virus responsible, human immunodeficiency virus, quickly identified, but also that drugs to attack the virus rapidly became available. Today, the success of highly active antiretroviral therapy (HAART) means that HIV infection is largely seen as a chronic condition that can be successfully managed.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts